Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research. OCRF Scientific Advisory Committee member Douglas A. Levine, MD, highlighted research relevant to ovarian cancer patients presented at the American Society of Clinical Oncology (ASCO), as well as the annual meetings of the American Association for Cancer Research (AACR) and the Society of Gynecologic Oncology (SGO). Watch the ovarian cancer research updates webinar now.
Douglas A. Levine, MD
Dr. Levine is Director of Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center, Head of the Gynecology Research Laboratory and Professor in Division of Gynecologic Oncology, Department of OB/GYN at NYU Langone Medical Center in New York City. Dr. Levine came to NYU in early May 2016, after a distinguished career at Memorial Sloan Kettering Cancer Center.
A prolific researcher and educator, Dr. Levine has authored or co-authored more than 150 peer-reviewed publications and two textbooks. In addition to his many academic honors and distinctions, he has been awarded the American Congress of Obstetricians and Gynecologists Mentor Award; served as co-chair of the American Association for Cancer Research Special Conference on Ovarian Cancer; received the 2013 Foundation for Women’s Cancer Excellence in Ovarian Cancer Research Prize; and was recently named the Assistant Dean of the Department of Defense Ovarian Cancer Academy. He is also a member of OCRFA’s Scientific Advisory Committee, and a former grantee.
After graduating from Franklin and Marshall College in Pennsylvania, Dr. Levine completed medical school at the Mount Sinai School of Medicine, and his residency in obstetrics and gynecology at Mount Sinai Medical Center.